期刊论文详细信息
BMB Reports
Drug resistance of bladder cancer cells through activation of ABCG2 by FOXM1
Won-Tae Kim^11  Yun-Gil Roh^12  Se-Ra Lee^23  Jin-Woong Chung^14  Mi-Hye Mun^15  Mi-So Jeong^16 
[1] Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, Korea^4;Department of Biological Science, College of Natural Science, Dong-A University, Busan 49315, Korea^1;Department of Urology, Medical Research Institute, Pusan National University Hospital, Busan 49241, Korea^5;Department of Urology, Research Institute for Convergence of Biochemical Science and Technology, Pusan National University Yangsan Hospital, Yangsan 50612, Korea^6;Division of Drug Development Optimization, Osong Medical Innovation Foundation (KBio), Chungbuk 28160, Korea^2;Drug Disease Target Team, Korea Basic Science Institute, Daejeon 34133, Korea^3
关键词: ABCG2;   
DOI  :  10.5483/BMBRep.2018.51.2.222
学科分类:生物化学/生物物理
来源: Korean Society for Biochemistry and Molecular Biology
PDF
【 摘 要 】

Recurrence is a serious problem in patients with bladder cancer. The hypothesis for recurrence was that the proliferation of drug-resistant cells was reported, and this study focused on drug resistance due to drug efflux. Previous studies have identified FOXM1 as the key gene for recurrence. We found that FOXM1 inhibition decreased drug efflux activity and increased sensitivity to Doxorubicin. Therefore, we examined whether the expression of ABC transporter gene related to drug efflux is regulated by FOXM1. As a result, ABCG2, one of the genes involved in drug efflux, has been identified as a new target for FOXM1. We also demonstrated direct transcriptional regulation of ABCG2 by FOXM1 using ChIP assay. Consequently, in the presence of the drug, FOXM1 is proposed to directly activate ABCG2 to increase the drug efflux activation and drug resistance, thereby involving chemoresistance of bladder cancer cells. Therefore, we suggest that FOXM1 and ABCG2 may be useful targets and important parameters in the treatment of bladder cancer.

【 授权许可】

Unknown   

【 预 览 】
附件列表
Files Size Format View
RO201910258072455ZK.pdf 4210KB PDF download
  文献评价指标  
  下载次数:6次 浏览次数:10次